Business Wire

MINDEROO-FOUNDATION

9.5.2022 08:23:07 CEST | Business Wire | Press release

Share
Global Plastic Watch: Satellite Eyes Pinpoint Waste From Space to Reduce Ocean Pollution

A cutting-edge new tool developed by Minderoo Foundation has identified thousands of waste sites across 25 countries for the first time using advanced satellite data technology and machine learning to measure piles of plastic waste from space.

Global Plastic Watch (globalplasticwatch.org ) is a tool which combines earth observation with artificial intelligence to create the first-ever near-real-time high-resolution map of plastic pollution. This is the largest open-source dataset of plastic waste across dozens of countries. The aim of the tool is to help authorities to better manage plastic leakage into the marine environment.

Global Plastic Watch uses remote sensing satellite imagery from the European Space Agency and a first-of-its-kind machine learned model created in collaboration with award winning Digital Product Agency for the Environment, Earthrise Media . The tool is able to determine the size and scale of land-based plastic waste sites, a major factor in fueling the growing problem of plastic pollution of the world’s rivers and oceans.

The data gathered provides a historical first and authoritative insight into one of the world’s most intractable environmental challenges – a deluge of plastic pollution which is threatening the oceans, harming communities, marine life, animal and human health. By using it, governments, industry and communities can evaluate and monitor the risk of land-based plastic waste sites, as well as prioritise investments in solutions.

The countries mapped so far include all of South-East Asia, Australia, and the countries identified by research published in Science Advances as accounting for high rates of plastic emissions into the ocean.

Dr Andrew Forrest AO, Chairman and Co-Founder of the Minderoo Foundation described data and transparency as important tools to fight plastic waste, and until now, it has been difficult to effectively identify and measure plastic waste build-up in a systematic, standardised way.

“Generally, the world has no idea how dangerous plastic waste is to the organic environment, particularly humans. The destination for every piece of plastic is nano-plastic, which has both poisonous and cutting attributes able to mutilate cells and even penetrate the human blood brain barrier,” Dr Forrest said.

“Preventing illegal and legal plastic waste stockpiles entering the oceanic environment is critical to limit this harm. Once in the ocean, through both mixing, absorption and ingestion by animals, this plastic will officially enter the human environment.

Using artificial Intelligence and satellite data, Minderoo Foundation has produced the first-ever map of plastic waste build up. Most of our data about plastic waste comes from models and estimates. Now our understanding is informed by real data that can be used to guide solutions.

Global Plastic Watch arms governments and researchers around the world with data that can better guide effective waste management interventions, ensuring land-based waste doesn’t end up in our oceans,” Dr Forrest said. “We want to work with governments to ensure this tool can also help to support policy change where needed.”

Dr Fabien Laurier, Lead for Technology and Innovation, and Ocean Conservation at Minderoo Foundation said some of the Global Plastic Watch findings were surprising.

“We know that land-based leakage contributes up to 91 per cent of the plastic waste that enters the ocean,” Dr Laurier said. “Global Plastic Watch has revealed that many large-scale waste sites across the first 25 countries we have mapped were previously undocumented and the number of sites is much higher than expected.”

The government of Indonesia is working with Minderoo Foundation to increase its recycling capacity to double recycling rates by developing capacity for an additional one million tonnes per year by 2025.

Dr Nani Hendiarti, Deputy for Environment and Forestry Management Coordination, Coordinating Ministry for Maritime Affairs and Investment, Indonesia, congratulated Minderoo Foundation on the public launch of the Global Plastic Watch.

“Global Plastic Watch is very helpful for identifying undocumented or illegal waste dump sites in Indonesia,” Dr Hendiarti said. “That has enabled us to prioritise areas in need of better waste management policies and actions. Therefore, it plays an integral role in accelerating the government’s waste management achievements across all regions in the country.”

Indonesian National Plastic Action Partnership (NPAP) Chair, Sri Indrastuti Hadiputranto, said tackling the challenge of plastic pollution in Indonesia, like in many other places in the world is going to require a collaborative effort from the public, private and civil society sectors, and its measurement is without exception.

“Global Plastic Watch is a data aggregator and monitoring platform on plastic waste,” Ms. Hadiputranto said. “It’s a timely innovation for policymakers, practitioners and advocates that believe in the importance of evidence-based policy making to advance our goal in reducing 70 per cent of ocean leakage by 2025. I believe more data-oriented innovations like Global Plastic Watch will lead us to a more sustainable policy outcome and improving collaborations in data collections in Indonesia.”

Global Plastic Watch is a tool aimed at supporting country-level efforts to understand the magnitudes and effects of land-based plastic waste sites, to enable them to better address undocumented sites and monitor those that pose environmental and health concerns. The data is also expected to guide direct investments in waste infrastructure in the areas that need it the most.

The development of the Global Plastic Watch tool follows the Plastic Waste Makers Index released in 2021, that revealed the true scale and sources of the global plastic waste crisis.

Globally, a 30 per cent increase in the production of single-use plastic is projected over the next five years. The Minderoo Foundation No Plastic Waste initiative believes this growth in production will lead to an extra three trillion items of throwaway plastic waste by 2025.

Global Plastic Watch will continue to work with partners to refine the Artificial Intelligence model and technology to further increase its accuracy as it expands its coverage to new sites and countries throughout 2022.

Global Plastic Watch site: globalplasticwatch.org
Global Plastic Watch project site: Minderoo.org/global-plastic-watch/

LINK TO PHOTOS (Password: k3YBL4TciY) | INTERVIEWS AND B-ROLL HERE | 2:17 VIDEO EDIT WITH ENGLISH NARRATION HERE |

About Minderoo Foundation:

Established by Andrew and Nicola Forrest in 2001, Minderoo Foundation is a modern philanthropic organisation seeking to break down barriers, innovate and drive positive, lasting change. Minderoo Foundation is proudly Australian, with key initiatives spanning from ocean research and ending slavery, to collaboration against cancer and building community projects.

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces Positive CHMP Opinion for Opzelura® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 13:30:00 CEST | Press release

If approved, Opzelura® (ruxolitinib) cream will be the first steroid-free, topical JAK treatment option in the European Union (EU) for adults with moderate atopic dermatitis (AD) for whom standard topical therapies have failedAD, the most common type of eczema which affects 230 million people globally,1 is a chronic, recurring, inflammatory and highly pruritic (itchy) skin condition that can have a significant impact on daily life2Phase 3 TRuE‑AD4 data supporting the positive CHMP opinion demonstrated that ruxolitinib cream met both co‑primary endpoints at Week 8, maintained disease control with as-needed treatment through Week 24 and was well tolerated3,4,5 Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids

Datroway® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 13:00:00 CEST | Press release

Recommendation based on TROPION-Breast02 phase 3 trial where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival If approved, Datroway has potential to be the first TROP2 directed antibody drug conjugate for patients in EU with a demonstrated overall survival benefit as first-line treatment Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use

DAYBU®(trofinetide) Recommended for Approval in the European Union by CHMP26.6.2026 12:49:00 CEST | Press release

-- European Commission decision expected in the coming months-- If approved, DAYBU®would become the first treatment for neurobehavioral symptoms of Rett syndrome in the European Union Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion following a re-examination procedure, recommending the granting of a marketing authorization for DAYBU® (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older. If granted marketing authorization by the European Commission, DAYBU® would be the first therapy approved for this indication in the European Union (EU). “The CHMP’s positive opinion for DAYBU® is an important milestone in our mission to bring this innovative therapy to the EU, where there are no therapies specifically approved for the neurobehavioral symptoms of this devastating

HTEC Showcases Lakebase Branching at Databricks’ Data & AI Summit26.6.2026 11:18:00 CEST | Press release

HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. The Solution was developed in collaboration with a leading risk and compliance technology provider who serves financial institutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260626875859/en/ HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. Solving Critical Development Bottlenecks in Regulated Environments At the core of the collaboration was a shared challenge: how to enable modern data workflows in an envi

Stallergenes Greer Named One of Switzerland’s Best Managed Companies for 202626.6.2026 10:28:00 CEST | Press release

Stallergenes Greer, a global leader in allergy care, has been recognised for its overall business performance, company culture, and sustained growth by receiving the prestigious 2026 Switzerland’s Best Managed Companies award. The 2026 Best Managed Companies programme award winners are among Switzerland’s best private companies. The awards are derived from Deloitte’s global Best Managed Companies awards programme, an internationally recognised programme that evaluates businesses based on their leadership in the areas of strategy, culture and commitment, capabilities, innovation, governance and financial performance. Applicants are evaluated by an independent jury of experts. The evaluation of the Switzerland awards is based on more than 30 years of observed practice from the global awards programme that has been rolled out in 50+ countries worldwide. This recognition reflects Stallergenes Greer's consistent ability to deliver on its strategic vision while maintaining the operational di

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye